Transcatheter heart valve interventions: where are we? Where are we going?
Eur Heart J
; 40(5): 422-440, 2019 02 01.
Article
em En
| MEDLINE
| ID: mdl-30608523
ABSTRACT
Transcatheter heart valve interventions have transformed the outcomes of patients with valvular heart disease (VHD) who are unfavourable candidates for surgery. Technological advances have allowed extension of these interventions to younger or lower risk patients and those with other forms of VHD and may in the future permit earlier treatment of VHD in less symptomatic patients or those with moderate disease. The balance of risks and benefits is likely to differ between lower and higher risk patients, and more evidence is needed to evaluate the net benefit of transcatheter technology in these groups. As academic researchers, clinicians, industry, and patient stakeholders collaborate to research these broader indications for transcatheter valve interventions, it is essential to address (i) device durability and deliverability, (ii) specific anatomical needs (e.g. bicuspid aortic valves, aortic regurgitation, mitral and tricuspid valve disease), (iii) operator training, and (iv) the reinforced importance of the multidisciplinary Heart Team.
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Próteses Valvulares Cardíacas
/
Implante de Prótese de Valva Cardíaca
/
Doenças das Valvas Cardíacas
/
Valvas Cardíacas
Limite:
Humans
Idioma:
En
Revista:
Eur Heart J
Ano de publicação:
2019
Tipo de documento:
Article
País de afiliação:
Reino Unido